Increased maternal serum human chorionic gonadotropin concentrations are an independent risk factor for SGA in dichorionic twin gestations

References

• McDuffie R S, Jr, Haverkamp A D, Stark C F, et al. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: Two-year experience in a health maintenance organization. J Matern Fetal Med 1996; 5: 70–73
   PubMedGoogle Scholar
• Chao A S, Chung C L, Wu C D, et al. Second trimester maternal serum screening using alpha fetoprotein, free beta human chorionic gonadotropin and maternal age specific risk: Result of chromosomal abnormalities detected in screen positive for Down syndrome in an Asian population. Acta Obstet Gynecol Scand 1999; 78: 393–397
   PubMed Web of Science ®Google Scholar
• Spencer K. Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome. Prenat Diagn 2000; 20: 652–656
   PubMed Web of Science ®Google Scholar
• Haddad B, Abirached F, Louis-Sylvestre C, et al. Predictive value of early human chorionic gonadotrophin serum profiles for fetal growth retardation. Hum Reprod 1999; 14: 2872–2875
   PubMed Web of Science ®Google Scholar
• Muller F, Aegerter P, Boue A. Prospective maternal serum human chorionic gonadotropin screening for the risk of fetal chromosome anomalies and neonatal death. Prenat Diagn 1993; 13: 29–43
   PubMed Web of Science ®Google Scholar
• Luckas M, Hawe J, Meekins J, et al. Second trimester serum free beta human chorionic gonadotropin levels as a predictor of pre-eclampsia. Acta Obstet Gynecol Scand 1998; 77: 381–384
   PubMed Web of Science ®Google Scholar
• Fejgin M D, Kedar I, Amiel A, et al. Elevated hCG as an isolated finding during the second trimester biochemical screen: genetic, ultrasonic, and perinatal significance. Prenat Diagn 1997; 17: 1027–1031
   PubMed Web of Science ®Google Scholar
• Chandra S, Scott H, Dodds L, et al. Unexplained elevated maternal serum alpha-fetoprotein and/or human chorionic gonadotropin and the risk of adverse outcomes. Am J Obstet Gynecol 2003; 189: 775–781
   PubMed Web of Science ®Google Scholar
• Crocker I P, Cooper S, Ong S C, et al. Differences in apoptotic susceptibility of cytotrophoblasts and syncytiotrophoblasts in normal pregnancy to those complicated with preeclampsia and intrauterine growth restriction. Am J Pathol 2003; 162: 637–643
   PubMed Web of Science ®Google Scholar
• Chitayat D, Farrell S A, Huang T, et al. Double-positive maternal serum screening results for down syndrome and open neural tube defects: An indicator for fetal structural or chromosomal abnormalities and adverse obstetric outcomes. Am J Obstet Gynecol 2002; 187: 758–763
   PubMed Web of Science ®Google Scholar
• Vaughan J E, Walsh S W. Oxidative stress reproduces placental abnormalities of preeclampsia. Hypertens Preg 2002; 21: 205–223
   PubMed Web of Science ®Google Scholar
• Hershkovitz R, Erez O, Sheiner E, et al. Elevated maternal mid-trimester chorionic gonadotropin ⩾ 4 MoM is associated with fetal cerebral blood flow redistribution. Acta Obstet Gynecol Scand 2003; 82: 22–27
   PubMed Web of Science ®Google Scholar
• Raty R, Virtanen A, Koskinen P, et al. Maternal midtrimester serum AFP and free beta-hCG levels in in vitro fertilization twin pregnancies. Prenat Diagn 2000; 20: 221–223
   PubMed Web of Science ®Google Scholar
• O'Brien J E, Dvorin E, Yaron Y, et al. Differential increases in AFP, hCG, and uE3 in twin pregnancies: Impact on attempts to quantify Down syndrome screening calculations. Am J Med Genet 1997; 73: 109–112
   PubMed Web of Science ®Google Scholar
• Neveux L M, Palomaki G E, Knight G J, et al. Multiple marker screening for Down syndrome in twin pregnancies. Prenat Diagn 1996; 16: 29–34
   PubMed Web of Science ®Google Scholar
• Lepage N, Chitayat D, Kingdom J, et al. Association between second-trimester isolated high maternal serum maternal serum human chorionic gonadotropin levels and obstetric complications in singleton and twin pregnancies. Am J Obstet Gynecol 2003; 188: 1354–1359
   PubMed Web of Science ®Google Scholar
• Cuckle H. Established markers in second trimester maternal serum. Early Hum Develop 1996; 47(Suppl.)S27–S29
   PubMedGoogle Scholar
• Benn P. Improved antenatal screening for Down's syndrome. Lancet 2003; 8: 794–795
   Google Scholar
• Fox H, Path M C. Effect of hypoxia on trophoblast in organ culture: A morphologic and autoradiographic study. Am J Obstet Gynecol 1970; 107: 1058–1064
   PubMed Web of Science ®Google Scholar
• Morssink L P, Heringa M P, Bekhius J R, et al. The HELLP syndrome: Its association with unexplained elevation of MSAFP and MSHCG in the second trimester. Prenat Diagn 1997; 17: 601–605
   PubMed Web of Science ®Google Scholar
• Lieppman R E, Williams M A, Cheng E Y, et al. An association between elevated levels of human chorionic gonadotropin in the midtrimester and adverse pregnancy outcome. Am J Obstet Gynecol 1993; 168: 1852–1856
   PubMed Web of Science ®Google Scholar
• Morssink L P, Herringa M P, Beekhius J R, et al. The association between hypertensive disorders of pregnancy and abnormal second-trimester maternal serum levels of hCG and alpha-fetoprotein. Obstet Gynecol 1997; 89: 666–670
   PubMed Web of Science ®Google Scholar
• Morssink L P, Kornman L H, Beekhius J R, et al. Abnormal levels of maternal serum human chorionic gonadotropin and alpha-fetoprotein in the second trimester: Relation to fetal weight and preterm delivery. Prenat Diagn 1995; 15: 1041–1046
   PubMed Web of Science ®Google Scholar
• Tanaka M, Natori M, Kohno H, et al. Fetal growth in patients with elevated maternal serum hCG levels. Obstet Gynecol 1993; 81: 341–343
   PubMed Web of Science ®Google Scholar
• Luckas M J, Sandland R, Hawe J, et al. Fetal growth retardation and second trimester maternal serum human chorionic gonadotropin levels. Placenta 1998; 19: 143–147
   PubMed Web of Science ®Google Scholar
• Lockwood C J, Kuczynski E. Markers of risk for preterm delivery. J Perinat Med 1999; 27: 5–20
   PubMed Web of Science ®Google Scholar
• Gonen R, Perez R, David M, et al. The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications. Obstet Gynecol 1992; 80: 83–86
   PubMed Web of Science ®Google Scholar
• Palacio M, Jauniaux E, Kingdom J, et al. Perinatal outcome in pregnancies with a positive serum screening for Down's syndrome due to elevated levels of free beta-human chorionic gonadotropin. Ultrasound Obstet Gynecol 1999; 13: 58–62
   PubMed Web of Science ®Google Scholar
• Niemimaa M, Suonpaa M, Heinonen S, et al. Maternal serum human chorionic gonadotrophin and pregnancy-associated plasma protein A in twin pregnancies in the first trimester. Prenat Diagn 2002; 22: 183–185
   PubMed Web of Science ®Google Scholar